Inferno XInferno X🃏All Genesect cards
Ask about Genesect
Genesect #8 Pokémon card from Japanese Inferno X
Japanese

Genesect 8/80

Inferno X· Language: Japanese

Find this card on eBay

Affiliate link · we may earn commission

Genesect #8 from Japanese Inferno X currently trades at $1.41 raw, with PSA 10 copies reaching $36.34 — a 25.8x grade premium.
Current Prices (USD)
Ungraded
$1.41
PSA 7
$12.00
PSA 8
$12.00
PSA 9
$12.00
PSA 10
$36.34
ACE 10
BGS 10 Black
$235.00
CGC 10 Pristine
$40.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Genesect 8/80 from Inferno X has a current raw market value of $1.41.

Current raw value
$1.41
PSA 9 value
$12.00
PSA 10 value
$36.34
PSA 10 premium vs raw
25.8× raw
View all cards from Inferno X
Collector Intel
25.8x
Raw → PSA 10
High-risk grade
8.5x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 26x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$36
PSA 10 Value
+$10
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$128.5x raw
PSA 10$3625.8x raw

Frequently asked questions

How much is Genesect #8 from Japanese Inferno X worth?+
Genesect #8 from Japanese Inferno X is currently worth Raw: $1.41, PSA 9: $12.00, PSA 10: $36.34 based on recent sold listings. Prices update daily from real eBay sales.
Is Genesect #8 worth grading?+
The PSA 10 price of $36.34 is 25.8× the raw price of $1.41. After a ~$25 grading fee, a PSA 10 result would net approximately $34.93 — assuming the card grades a 10.
Where do PokePrices Genesect #8 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.